Clinical trial
Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for…
NCT00448903 · Rovi Pharmaceuticals Laboratories, Industry · Completed
Key facts
| NCT number | NCT00448903 |
|---|---|
| Title | Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers |
| Official title | Multicentric, Randomized, Double-blind, Controlled Clinical Trial to Assess the Efficacy and Safety of Bemiparin Sodium as Treatment of Diabetic Foot Ulcers |
| Lead sponsor | Rovi Pharmaceuticals Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Foot Ulcer, Diabetic |
| Intervention type | Drug |
| Interventions | Bemiparin, Placebo |
| Enrollment | 329 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Apr 1, 2010 |
| First posted | Mar 19, 2007 |
| Last update posted | Mar 17, 2011 |
| Countries | Croatia, Poland, Romania, Russia, Serbia, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: